AVDL Research and Charts

AVDL - Avadel Pharmaceuticals PLC ADR (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 2025-06-02 (Delayed quote data 2025-04-03)

Last 7.20	Change ⇓ -0.26 (-3.49%)	Volume 1,073,639
	Open 7.29	High 7.40	Low 7.07

8EMA (Daily) 7.74	40EMA (Daily) 8.25	50EMA (Daily) 8.42	STO (Daily) 12.276	MACD Hist (Daily) -0.224
8EMA (Weekly) 8.080	40EMA (Weekly) 10.80	50EMA (Weekly) 11.24	STO (Weekly) 16.289	MACD Hist (Weekly) 0.080


Company Profile
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.